As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters

As Sandoz prepares to spin off from Novartis into its own generics and biosimilars business, the company has settled on a location for its new headquarters.

The company's new digs will be close to home in Basel, Switzerland, which is already where Novartis is based. Specifically, Sandoz will be operating from the center of the city, right near the Basel SBB train station, the company said in a statement.